5
Clinical Trials associated with HeartiCellgram-AMIThe study of intravenous administration of autologous cranial bone derived mesenchymal stem cells for moderate or severe cerebral infarction patients needed decompressive surgery
Start Date19 Mar 2020 |
Sponsor / Collaborator- |
A Pilot Study on the Efficacy of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Systemic Lupus Erythematosus
Start Date02 Mar 2015 |
Sponsor / Collaborator- |
/ Active, not recruitingPhase 3 A Randomized,Open labEled, muLticenter Trial for Safety and Efficacy of Intracoronary Adult Human Mesenchymal stEm Cells Acute Myocardial inFarction
Through the injection of Hearticellgram-AMI into acute myocardial infarction patients who are the primary targets of the drug, long term efficacy in the improvement of the left ventricle ejection fraction upon the first cell treatment is to be evaluated and compared with the current existing treatments (contemporary drug treatment).
This study will also compare the efficacy and safety of single dose of hearticellgram-AMI.
100 Clinical Results associated with HeartiCellgram-AMI
100 Translational Medicine associated with HeartiCellgram-AMI
100 Patents (Medical) associated with HeartiCellgram-AMI
100 Deals associated with HeartiCellgram-AMI